Navigation Links
Fiserv crosses Fortune 500 threshold

Milwaukee, Wis. Fiserv, Inc., the Brookfield-based provider of financial and health benefits technology, is one of 10 Wisconsin companies to make the annual Fortune 500 list of the largest revenue-producing companies in the United States.

Fiserv, which reported $4.1 billion in annual revenue and earned $516 million in 2005, cracked the l......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 04/05/06


Page: 1

Related biology technology :

1. Fiserv reports $113.5 million in Q1 profit
2. Former Fiserv exec to enter Business Hall of Fame
3. Fiserv acquires crime management software firm
4. Fiserv posts 30 percent quarterly loss
5. Fiserv reports stronger earnings and revenues
6. Fiservs Banklink chosen by Union Bank of California
7. Fiserv makes over $1 billion, but profits decline
8. Fiserv to partner with PassMark Security
9. Fiserv acquires insurance, training product lines
10. Fiserv unit adds healthcare payment processor
11. Fiserv Reports Strong Earnings for Third Quarter of 2005
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):